Have you heard about a newly approved treatment for alopecia areata? You can learn more here. More drugs are going through clinical trials as researchers look for better ways to use currently approved drugs and new ones. Olumiant Olumiant™ (baricitinib) was approved for the treatment of severe alopecia areata in adults in June 2022. Read frequently asked questions about Olumiant. LITFULO LITFULO™ (ritlecitinib) was approved for the treatment of severe alopecia areata in indivduals ages 12 and up in June 2023. Frequently asked questions about LITFULO coming soon. Read Pfizers’s press release here.